Article
Integrating multi-omics in bile for biomarker discovery in cholangiocarcinoma
26 Aug 2025
Abstract excerpt
BACKGROUND: Cholangiocarcinoma (CCA) is an aggressive cancer with a poor prognosis. Histopathology evaluation of brushings and biopsies obtained during endoscopic retrograde cholangiopancreatography (ERCP) currently remains the main method of diagnosis, which has limited sensitivity for malignancy detection. Our study aimed to identify human bile-derived biomarkers to improve CCA diagnosis. Bile samples were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
